Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I agree newman2021.
death of cancer cells pic.twitter.com/g4g3Jtnb3i
— Slava Bobrov (@slava__bobrov) July 19, 2024
The revolutionary DCVax-L vaccine has allowed GBM patient Jim Power to live a good life 10 years after his first brain surgery. I wish him at least ten more years of good fortune!
July 27, 2014 my Dad went in for his first Craniotomy only to be diagnosed with GBM.
— Kristyn Power, CFA (@KristynPower) July 28, 2024
At that time watching the 2024 Paris Olympics was a very longshot. I just asked him what he wanted to post “Made 10 years, looking for 10 more.” Sending all patients and families love. ❤️ pic.twitter.com/gk3EQG4zvN
This is him getting his sixth shot in the arm with Professor Ashkan at King’s College Hospital in May. We don’t know the vaccine works till it works of course ... but so far things look good.
— rj (@sharpie510) July 23, 2024
🙏
The DCVax® Platform
💪$nwbo #DCVax #Glioblastoma #GBM #HOPEhttps://t.co/98rnusvxd6 pic.twitter.com/b3KRJ3CIjj
A message from Owain’s family, thank you to everyone who has supported them. #fundsforowain pic.twitter.com/uyIBTMXkvN
— FundsForOwain (@FundsForOwain) June 29, 2024
Thanks ATLnsider.
Marnix Bosch will do the presentation.
17th July.
Pawel Kalinski MD, PhD
I’m so sorry to hear about the passing of Shenell Malloy.
She was such a beautiful soul and human. My prayers are with her family.
https://www.instagram.com/fightingpretty/p/C8F508nyVbz/
— Tejas Kulkarni (@tejasdkulkarni) June 15, 2024
I am currently holding my dad's cryopreserved brain tumor samples in hopes of creating a personalized vaccine for immunotherapy. However, there are some critical and time-sensitive questions in the attached post: https://t.co/3lxkUruGRe
— Tejas Kulkarni (@tejasdkulkarni) June 15, 2024
This is time-sensitive so would appreciate… pic.twitter.com/Jxd52m3UlW
15th June 2024
09:30 - 10:20 AM
NOVEL RESEARCH IN THE NEUROSCIENCES: DEVELOPING A VACCINATION FOR GBM.
Speaker: Professor Keyoumars Ashkan
Gainsford Lecture Theatre.
Westen Education Centre
KCL Denmark Hill Campus
London.
26th June
🧠🧬💉This month we’re thrilled to welcome Prof. Keyoumars Ashkan from @KingsNeuro who will be talking us through Glioblastoma
— Brain School (@BrainSchool101) June 3, 2024
research!
🔬 Not an event to miss! We cannot wait!
🥳 As always, catch up drinks afterwards!
⏰ Wed 26th June, 7:00pm
🗺️ @RCSnews pic.twitter.com/DlT379wC7b
🔊 Speaker Announcement!
— KCL Neurosurgery Society (@KCLneurosurgery) May 19, 2024
We are pleased to announce the next speaker for our upcoming 2024 Conference 'Landmarks in Neurosurgery'!
Professor Keyoumars Ashkan is a leading neurosurgery specialist and works as the lead for functional and oncological neurosurgery at KCH!! 🧠🧠🧠 pic.twitter.com/XBQDgP17JF
Not sure who deserves credit for this, but enjoy! #ASCO24 pic.twitter.com/eoRrA3S4rk
— Deborah Doroshow (@DDoroshow) June 2, 2024
Professor Keyoumars Ashkan
Consultation fees.
New appointment: £299.
Follow-up appointment:£247.
https://www.hcahealthcare.co.uk/finder/specialists/professor-keyoumars-ashkan
#ASCO24 pic.twitter.com/GTGYg7eYcx
— Dr. Nagla Abdel Karim (@NaglaAKarimMD) June 1, 2024
May 29
Nemesis18:
Calendar days.
I don't believe that March 7th marked the end of the phase1 assessment process
It seems logical that the 150-day assessment period began on January 24, 2024, when the initial validation was confirmed. The March 7, 2024, confirmation likely served as an additional administrative check within the ongoing Phase 1 review process to ensure all documentation was in place and that the application was qualified for the 150-day assessment route.
StonkMaster,
I believe the 150-day assessment begane on Jan.24
IMO, it doesn't make sense to suggest that the 150-day assessment would begin on March 7, given that the standard process typically takes 210 days. Starting the rapid assessment 43 days after the validation confirmation would unnecessarily delay the process. It is logical to conclude that the 150-day assessment began on January 24, when the MAA initially passed validation.
CHATgpt:
May 9, 2024
Les Goldman says "they are on track for accelerated approval (150- day assessment)" witch is new information.
We know that Northwest Biotherapeutics has requested the MHRA to allow the 150-day assessment route.
December 21, 2023
Children and teenagers could benefit after a new targeted combination treatment for a rare, aggressive form of brain cancer was recommended today.
— NICE (@NICEComms) April 24, 2024
Find out more about how dabrafenib with trametinib works: https://t.co/LCkav3pgIP#NICENews pic.twitter.com/BKvjuKcVdo
TODAY MAY 22
7-8 a.m.
Join via ZOOM
Meeting ID: 913 1277 5742
Tomorrow we are honored to host @EKNduom from @EmoryNeurosurg for #Neurosurgery #GrandRounds. Esteemed surgeon, scientist, #Advocate, and leader @CNS_Update, we are excited for his talk "New Approaches to Immune Therapy for #Glioblastoma: Lessons Learned". @GWSMHS #CancerMoonshot pic.twitter.com/pnFlB1j2fI
— George Washington Neurosurgery (@GWnsgy) May 21, 2024
At the tumor session with Dr. Liau and Dr. Lim! #AANS2024 @MichaelLimMD @UCLANsgy @IsaacYangMD @AANSNeuro @StanfordNsurg #WhatMatters2Me pic.twitter.com/h5mFIOSmGc
— The Yang Lab (@TheYangLab1) May 5, 2024
AANS2024 Chicago
Monday, May 6, 2024
11:06 AM – 11:26 AM CT
Location: S503ab
Linda Liau – Immunotherapy.
Congratulations to the stellar lineup of UCLA #Neurosurgery Faculty & Residents who are scheduled at the @AANSNeuro Annual Meeting this weekend! Schedule: https://t.co/y6CRiQe2fi@ausaf @geoffreycolbymd @SpineNeuro @inspired_brain @IsaacYangMD @ShivaniBaisi_MD @brainbro #AANS2024 pic.twitter.com/oQ8oHKHmyz
— UCLA Neurosurgery 🧠 (@UCLANsgy) May 1, 2024
FORM 10-K/A (Amendment No. 1) filed April 29: https://www.otcmarkets.com/filing/html?id=17489512&guid=d5Q-kqGyIgi7B3h
Last Friday, we were honored to have Dr. Linda Liau as our 42nd Annual J. Jay Keegan Lecturer. It was an extraordinary afternoon for our residents with a phenomenal presentation and dinner to follow. We are so indebted to Dr. Liau for her time here in #Omaha. @unmc @UCLANsgy pic.twitter.com/tqb36hpn6w
— UNMC Department of Neurosurgery (@UNMC_NeuroSurg) April 22, 2024
Calendar days and not business (working) days.
From MHRA:
Guidance
International Recognition Procedure - supplementary information
Updated 8 April 2024
Ex,
EAMS medicines are provided free of charge to the NHS (National Health Service),‘Specials’ may be provided free of charge or charged (generating revenue).
From inspire.com:
I hope Dr.Mulholland’s next immunotherapy trial for people with glioblastoma (this summer?) is a combo trial with DCVax-L.
Thank you @Siobhain_Mc for campaigning on this issue. It would be amazing to get Dr Mulholland’s #immunotherapy trial for people with #glioblastoma up and running this summer. We’re with you! https://t.co/YWoEuSQ1q9
— The National Brain Appeal (@BrainAppeal) April 3, 2024
Diagnosed with a glioblastoma, Matthew is raising funds to pay for DC Vax-L treatment, which has the potential to extend his life, but is not available on the NHS. Access to new and better treatments - #ItsANoBrainer. Sign our open letter today: https://t.co/yvQSBzL5ta pic.twitter.com/oT4Dz7YB1v
— The Brain Tumour Charity (@BrainTumourOrg) March 25, 2024
Interesting Gofundme story.
Bo’s Brain Cancer Treatment.
2 days ago.
Smokey, I wish you a full recovery! Stay strong and never give up!